openPR Logo
Press release

Primary Angle-Closure Glaucoma Market is Set to Witness Huge Growth With a USD 340.82 Million at a CAGR of 6.1% During the Forecast Period 2028

07-21-2023 02:59 PM CET | Health & Medicine

Press release from: Data Bridge Market Research

Primary Angle-Closure Glaucoma Market is Set to Witness Huge

A worldwide Primary Angle-Closure Glaucoma Market research report is a verified and reliable source of information that gives a telescopic view of the existing market trends, emerging products, situations, and opportunities that drives the business toward success. This global market research report is organized by collecting market research data from different corners of the globe with an experienced team of language resources. The report serves the clients to tackle every strategic aspect including product development, product specification, exploring niche growth opportunities, application modelling, and new geographical markets. The universal market report also provides company profiles and contact information of the key market players in the key manufacturer's section.

The primary angle-closure glaucoma market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 6.1% in the forecast period of 2021 to 2028 and is expected to reach USD 340.82 million by 2028. Increasing prevalence of angle-closure glaucoma and advancement in surgical treatment of the disease are the key drivers for global primary angle-closure glaucoma market.

Glaucoma is a group of eye conditions that damage the optic nerve and the proper functioning of the optic nerve is necessary for good vision. This damage is often caused by abnormally high pressure in the eye. The primary angle-closure (PAC) is defined as appositional or synechial closure of the anterior chamber angle which can lead to aqueous outflow obstruction and raised IOP in the absence of glaucomatous optic neuropathy.

The increasing population of women globally and greater female-to-male ratio in angle-closure glaucoma due to various anatomical and hormonal factors showed the prevalence of the disease in women with increasing women population which is expected to drive the primary angle-closure glaucoma market in the forecasted period. The poor reimbursements are seen as a restraint for the primary angle-closure glaucoma market. The governing body for the approval of products has a significant role in the primary angle-closure glaucoma market growth. The increasing approval of the product for the primary angle-closure glaucoma is expected to boost the market in the forecasted period and will act as opportunities for the primary angle-closure glaucoma market growth. The risks associated with the micro-invasive glaucoma surgery acts as a challenge for the primary angle-closure glaucoma market.

Download the Exclusive Sample Report (Including Graphs, Charts & Table & Figures) @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-primary-angle-closure-glaucoma-market

Primary Angle-Closure Glaucoma Market Scope and Market Size

The primary angle-closure glaucoma market is segmented on the basis of the disease type, type, end user and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

On the basis of disease type, the primary angle-closure glaucoma market is segmented into acute angle-closure glaucoma and chronic angle-closure glaucoma. In 2021, acute angle-closure glaucoma segment is dominating in the primary angle-closure glaucoma market owing to the high incidence cases for acute cases.

On the basis of type, the primary angle-closure glaucoma market is segmented into diagnosis and treatment. In 2021, diagnosis segment is dominating in the primary angle-closure glaucoma market due to the primary test and secondary testing options available for the diagnosis and physicians after a proper diagnosis only prefer the medical procedure.

On the basis of end user, the primary angle-closure glaucoma market is segmented into hospitals, specialty clinics, ambulatory surgical centers and others. In 2021, hospitals segment is dominating the primary angle-closure glaucoma market as this segment is specialized in conducting various surgical interventions and has a large professional's portfolio available for giving the proper treatment.

On the basis of distribution channel, the primary angle-closure glaucoma market is segmented into direct tender, retail sales and others. In 2021, direct tender segment dominates the primary angle-closure glaucoma market as they are the primary source of procurement of diagnostic and surgical devices by healthcare organizations and specialty clinics.

Competitive Landscape and Primary Angle-Closure Glaucoma Market Share Analysis

The primary angle-closure glaucoma market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company's focus related to global primary angle-closure glaucoma market.

The major companies dealing in the global primary angle-closure glaucoma market report are Johnson & Johnson Vision Care, Inc. (a subsidiary of Johnson & Johnson Services Inc.), Aurolab, New World Medical, Inc., Sight Sciences, Inc., NIDEK CO., LTD, BVI, MicroSurgical Technology, Allergan (a subsidiary of AbbVie Inc.), Bausch & Lomb Incorporated (a subsidiary of Bausch Health Companies Inc.), Oertli Instrumente AG, Medisonic Equipments Pvt. Ltd., Omni Lens, APPASAMY ASSOCIATES, NOVAEYE MEDICAL, ZEISS International, Alcon Inc., LIGHTMED, Luneau Technology USA, Reichert, Inc. (a business unit of Ametek Inc.) and NEW VISION among other domestic and global players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Top Trendings Reports:-

https://dbmr006.blogspot.com/2023/07/randomization-and-trial-supply.html

https://dbmr006.blogspot.com/2023/07/artificial-saliva-market-is-set-to-grow.html

https://dbmr006.blogspot.com/2023/07/cell-separation-technology-market-is.html

https://dbmr006.blogspot.com/2023/07/dermatology-lasers-market-is-booming.html

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on

Contact us:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Corporatesales@databridgemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Primary Angle-Closure Glaucoma Market is Set to Witness Huge Growth With a USD 340.82 Million at a CAGR of 6.1% During the Forecast Period 2028 here

News-ID: 3141461 • Views:

More Releases from Data Bridge Market Research

Breast Prosthesis Market to Exhibit a Remarkable CAGR of 8.3% by 2031, Size, Share, Trends, Key Drivers, Demand, Opportunity Analysis and Competitive Outlook
Breast Prosthesis Market to Exhibit a Remarkable CAGR of 8.3% by 2031, Size, Sha …
Data Bridge Market Research analyzes that the global breast prosthesis market is expected to reach USD 594,575.57 thousand by 2031 from USD 319,959.41 thousand million in 2023, growing at a CAGR of 8.3% in the forecast period of 2024 to 2031. Market Definition: A breast prosthesis is an artificial breast form designed to replace all or part of a natural breast that has been removed due to mastectomy, lumpectomy, or other
X-Ray Fluorescence Analyser Market to Reach $2.32 Billion by 2030, Growing at a CAGR of 5.25%
X-Ray Fluorescence Analyser Market to Reach $2.32 Billion by 2030, Growing at a …
Leveraging a robust research methodology and meticulous data analysis, this report provides an in-depth exploration of the X-Ray Fluorescence Analyser Market. Our team of experts has compiled and analyzed extensive data sets, encompassing consumer behavior, market trends, and competitor analysis. This comprehensive report empowers you with the knowledge required to navigate the complexities of the market and make strategic decisions with confidence. Go beyond mere market data with X-Ray Fluorescence
Cardiovascular Disease Drug Market to Surge 5.02% Annually Through 2029, Reaching $230.24 Million
Cardiovascular Disease Drug Market to Surge 5.02% Annually Through 2029, Reachin …
Leveraging a robust research methodology and meticulous data analysis, this report provides an in-depth exploration of the Cardiovascular Disease Drug Market. Our team of experts has compiled and analyzed extensive data sets, encompassing consumer behavior, market trends, and competitor analysis. This comprehensive report empowers you with the knowledge required to navigate the complexities of the market and make strategic decisions with confidence. Go beyond mere market data with Cardiovascular Disease
Paint Can Market Poised for Steady Growth, Reaching $6.79 Billion by 2029 at a CAGR of 4.7%
Paint Can Market Poised for Steady Growth, Reaching $6.79 Billion by 2029 at a C …
Leveraging a robust research methodology and meticulous data analysis, this report provides an in-depth exploration of the Paint Can Market. Our team of experts has compiled and analyzed extensive data sets, encompassing consumer behavior, market trends, and competitor analysis. This comprehensive report empowers you with the knowledge required to navigate the complexities of the market and make strategic decisions with confidence. Go beyond mere market data with Paint Can Market.

All 5 Releases


More Releases for Glaucoma

Micro-Invasive Glaucoma Implants Micro-Invasive Glaucoma Implants
Global Micro-Invasive Glaucoma Implants Market Definition: Micro-invasive glaucoma implants is performed for the treatment of the open- angle glaucoma and is done through an ab- interno approach. It is very safe and provides faster recovery as compared to the traditional methods. They usually lower the intraocular by increasing the flow or reducing the production of the aqueous humor. Increasing cases of the glaucoma worldwide is the major factor fueling the
Glaucoma – Epidemiology Insights (2016-2028)
Glaucoma can be described as a group of diseases characterized by cupping of the optic nerve head and visual-field damage. These diseases differ from each other in terms of their causes, risk factors, demographics, symptoms, duration, treatment, and prognosis. Download the sample report @ https://www.pharmaproff.com/request-sample/1159 The common identifiable features for all forms of glaucoma are loss of retinal ganglion cells, thinning of the retinal nerve fiber layer, and cupping of the
Market Spotlight: Glaucoma
Boston, MA ReportsWorldwide has announced the addition of a new report title Market Spotlight: Glaucoma to its growing collection of premium market research reports. Glaucoma is not just one eye disease, but a group of eye conditions resulting in optic nerve damage, which may cause loss of vision and blindness. In glaucoma, damage to the optic nerve is usually caused by elevated intraocular pressure (IOP). IOP rises when passages that allow fluid
North America Glaucoma Therapeutics Market grows with growing awareness regardin …
Glaucoma Therapeutics Market: Scope and Methodology The research is a combination of primary and secondary research, conducted for understanding and arriving at trends, used to forecast the expected revenue of the major glaucoma therapeutics market in the near future. Primary research formed the bulk of our research efforts with information collected from in-depth interviews and discussions with a number of key industry experts and opinion leaders. Secondary research involved study
Glaucoma Treatment Market : Rising Geriatric Population And Healthcare Expenditu …
Glaucoma is a chronic, degenerative, permanent disorder whose rate increases essentially with age rather than causing immediate blindness. According to a survey of WHO, Glaucoma is the second most common cause of blindness affecting the population worldwide after cataract (47.9%). In general, Glaucoma occurs as after effects of increased intraocular pressure (IOP) brought about by an abnormality or malfunctioning of the eye drainage system. The normal IOP is in
Glaucoma Surgery Devices Market 2016: Glaucoma Systems, Glaucoma Laser Devices
Latest industry research report on Glaucoma surgery devices are used in the glaucoma treating procedure. These procedures include both surgical and laser therapies performed on a patient. The cases of blindness due to glaucoma is on rise across the several countries. Furthermore, the demand for both technologically as well as advanced surgical equipment has resulted in the popularity of glaucoma surgery devices industry, worldwide. Sudden increase in the aging population and